Clinical Trials Browser

Phase 2 × Nasopharyngeal Carcinoma × Bevacizumab × Clear all

Nasopharyngeal Carcinoma, Mesothelioma, Malignant, Adenocarcinoma, Mucinous, Adenoma, Islet Cell, Nasopharyngeal Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Neuroendocrine

NCT06364826 2024-04-15

Sintilimab Combination Therapy Plus IMRT in Nasopharyngeal Carcinoma

Phase 2 Not yet recruiting

60 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT04872582 2023-02-23

Efficacy and Safety of Sintilimab Plus Bevacizumab in Metastatic Nasopharyngeal Carcinoma After Failure of Platinum-based Chemotherapy: An Open-label Phase II Study

Phase 2 Unknown

33 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT04553510 2020-09-17

Treatment of Bevacizumab Followed by Steroid in RN

Phase 2 Unknown

86 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Brain Injuries, Radiation Injuries

NCT01621880 2019-01-09

BRAIN

Phase 2 Completed

112 enrolled 10 charts

Head & Neck

Nasopharyngeal Carcinoma, Radiation Injuries

NCT02250599 2015-12-30

Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal Carcinoma

Phase 2 Unknown

80 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

Clinical Trials

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

Sintilimab Combination Therapy Plus IMRT in Nasopharyngeal Carcinoma

Efficacy and Safety of Sintilimab Plus Bevacizumab in Metastatic Nasopharyngeal Carcinoma After Failure of Platinum-based Chemotherapy: An Open-label Phase II Study

Treatment of Bevacizumab Followed by Steroid in RN

BRAIN

Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal Carcinoma